ORIGINAL RESEARCH
Published on 08 Apr 2025
The transcription factor TSHZ3 promotes tumor immunosuppression and inhibits metastasis in lung adenocarcinoma
doi 10.3389/fimmu.2025.1519815
- 122 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Precision Oncology in Checkpoint Immunotherapy: Leveraging Predictive Biomarkers for Personalized Treatment
Precision Oncology in Checkpoint Immunotherapy: Leveraging Predictive Biomarkers for Personalized Treatment
4,000
Total downloads
16k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
SYSTEMATIC REVIEW
Accepted on 07 Apr 2025
The neoadjuvant immunotherapy for non-metastatic mismatch repair-deficient colorectal cancer: a systematic review
doi 10.3389/fimmu.2025.1540751
ORIGINAL RESEARCH
Accepted on 04 Apr 2025
To Determine the Role of TRIT1 in the Diagnosis, Prognosis and Immunoinvasion of Liver Hepatocellular Carcinoma
doi 10.3389/fimmu.2025.1563442
SYSTEMATIC REVIEW
Published on 26 Mar 2025
The efficacy and safety of PD-1/PD-L1 inhibitors in combination with chemotherapy as a first-line treatment for unresectable, locally advanced, HER2-negative gastric or gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
doi 10.3389/fimmu.2025.1566939
- 872 views
ORIGINAL RESEARCH
Published on 11 Mar 2025
Single-cell and transcriptome analyses revealed CTHRC1 a potential therapeutic target mediating invasion and tumor microenvironment in TNBC: experimental validation
doi 10.3389/fimmu.2025.1534981
- 460 views
ORIGINAL RESEARCH
Published on 04 Mar 2025
Integrative analysis of semaphorins family genes in colorectal cancer: implications for prognosis and immunotherapy
doi 10.3389/fimmu.2025.1536545
- 601 views
ORIGINAL RESEARCH
Published on 03 Mar 2025
Exploring radiation resistance-related genes in pancreatic cancer and their impact on patient prognosis and treatment
doi 10.3389/fimmu.2025.1524798
- 553 views
REVIEW
Published on 25 Feb 2025
Efficacy and safety of PD-1/PD-L1 inhibitors alone or in combination in the treatment of metastatic or advanced renal cell carcinoma: a network meta-analysis
doi 10.3389/fimmu.2025.1524497
- 659 views
ORIGINAL RESEARCH
Published on 21 Feb 2025
Prognostic significance of the inhibitory-to-stimulatory immune checkpoint ratio in patients with breast cancer
doi 10.3389/fonc.2025.1524861
- 422 views
ORIGINAL RESEARCH
Published on 03 Feb 2025
Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy
doi 10.3389/fimmu.2025.1487318
- 591 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma
doi 10.3389/fimmu.2024.1496095
- 681 views
ORIGINAL RESEARCH
Published on 17 Dec 2024
The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma
doi 10.3389/fonc.2024.1454709
- 574 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: